ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Ab Science Sa

Ab Science Sa (0Q77)

3.835
0.00
( 0.00% )
Updated: 19:00:00

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
3.835
Bid
3.74
Ask
3.93
Volume
63
0.00 Day's Range 0.00
3.835 52 Week Range 3.835
Market Cap
Previous Close
3.835
Open
-
Last Trade
61
@
0.884
(O)
Last Trade Time
06:06:45
Financial Volume
-
VWAP
-
Average Volume (3m)
827
Shares Outstanding
46,602,000
Dividend Yield
-
PE Ratio
-3.42
Earnings Per Share (EPS)
-0.26
Revenue
970k
Net Profit
-11.99M

About Ab Science Sa

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Paris, Paris, Fra
Founded
-
Ab Science Sa is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0Q77. The last closing price for Ab Science was 3.84 €. Over the last year, Ab Science shares have traded in a share price range of 3.835 € to 3.835 €.

Ab Science currently has 46,602,000 shares outstanding. The market capitalization of Ab Science is 178.72 € million. Ab Science has a price to earnings ratio (PE ratio) of -3.42.

0Q77 Latest News

AB Science provides a summary of the webcast held on December 16, 2024

AB Science provides a summary of the webcast held on December 16, 2024 PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON AB8939, A NOVEL MICROTUBULE DESTABILIZER ESCAPING MULTIDRUG RESISTANCE AND...

AB Science fournit un résumé de la conférence virtuelle qui s’est tenue le 16 décembre 2024

AB Science fournit un résumé de la conférence virtuelle qui s’est tenue le 16 décembre 2024 COMMUNIQUÉ DE PRESSE AB SCIENCE FAIT LE POINT SUR LA MOLECULE AB8939, UN NOUVEAU DÉSTABILISATEUR DE...

AB Science tiendra une conférence virtuelle le lundi 16 décembre 2024, de 17h30 à 18h30

AB Science tiendra une conférence virtuelle le lundi 16 décembre 2024, de 17h30 à 18h30 COMMUNIQUE DE PRESSE AB SCIENCE TIENDRA UNE CONFERENCE VIRTUELLE LE LUNDI 16 DECEMBRE 2024, DE 17H30 A 18H30...

AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET

AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY DECEMBER 16, 2024 FROM 5.30PM TO 6.30PM CET...

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN...

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS...

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL...

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR LA DEMANDE...

AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science

AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science          COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS AU PREMIER SEMESTRE...

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities          PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2024 AND THE KEY EVENTS...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1003.8353.8353.835213.835DE
4003.8353.8353.83515753.835DE
12003.8353.8353.8358273.835DE
26003.8353.8353.8355823.835DE
52003.8353.8353.83517833.835DE
156003.8353.8353.83545333.835DE
260003.8353.8353.83545703.835DE

0Q77 - Frequently Asked Questions (FAQ)

What is the current Ab Science share price?
The current share price of Ab Science is 3.835 €
How many Ab Science shares are in issue?
Ab Science has 46,602,000 shares in issue
What is the market cap of Ab Science?
The market capitalisation of Ab Science is EUR 178.72M
What is the 1 year trading range for Ab Science share price?
Ab Science has traded in the range of 3.835 € to 3.835 € during the past year
What is the PE ratio of Ab Science?
The price to earnings ratio of Ab Science is -3.42
What is the cash to sales ratio of Ab Science?
The cash to sales ratio of Ab Science is 42.31
What is the reporting currency for Ab Science?
Ab Science reports financial results in EUR
What is the latest annual turnover for Ab Science?
The latest annual turnover of Ab Science is EUR 970k
What is the latest annual profit for Ab Science?
The latest annual profit of Ab Science is EUR -11.99M
What is the registered address of Ab Science?
The registered address for Ab Science is 3 AVENUE GEORGE V, PARIS, PARIS, 75008
What is the Ab Science website address?
The website address for Ab Science is www.ab-science.com
Which industry sector does Ab Science operate in?
Ab Science operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WEBWebis Holdings Plc
0.075p
(36.36%)
87.77k
REVBRevolution Beauty Group Plc
18.30p
(30.71%)
2.09M
EMLEmmerson Plc
0.775p
(24.00%)
22.98M
AMGAtlas Metals Group Plc
11.50p
(21.05%)
422.77k
CGOContango Holdings Plc
1.50p
(20.00%)
1.49M
POLBPoolbeg Pharma Plc
4.35p
(-39.16%)
23.91M
THRUThruvision Group Plc
6.50p
(-18.75%)
167.34k
SYMESupply@me Capital Plc
0.003p
(-14.29%)
163.76M
VRSVersarien Plc
0.03p
(-14.29%)
39.78M
ALLAtlantic Lithium Limited
14.98p
(-13.31%)
2.63M
DGIDg Innovate Plc
0.0225p
(0.00%)
530.56M
TRPTower Resources Plc
0.0365p
(1.39%)
358.97M
NTVONativo Resources Plc
0.0019p
(0.00%)
201.32M
SYMESupply@me Capital Plc
0.003p
(-14.29%)
163.76M
CPXCap-xx Limited
0.165p
(6.45%)
147M

Discussion

View Full Feed
gp22 gp22 3 minutes ago
$BNRG: If you missed $MOB. $MTEK, $PRZO, $SPCB & the other microfloat Israel plays....Dont miss $BNRG @ $1.30s:
BNRG MOB MTEK
Pickme2 Pickme2 3 minutes ago
style="caret-color: rgb(0, 0, 0); color: rgba(0, 0, 0, 1); font-family: "times new roman"; font-size: 13.333333px; text-align: justify"THE PURCHASE OF THE SECURITIES OFFERED THROUGH THIS PROSPECTUS INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD CAREFULLY READ THE ENTIRE PROSPECTUS, INCLUDING THE SECTION
ATMH
Juntao Juntao 3 minutes ago
$AUTR https://www.otcmarkets.com/stock/AUTR/security
AUTR
firebag1 firebag1 3 minutes ago
yeah but it might happen..hope not...goood luk
HOLO
powerbattles powerbattles 3 minutes ago
$CTOR $1.24 ✨💎✨💎✨💎✨💎✨💎Next monster is one of the lowest floaters in the market. With Lymphir's FDA approval and another drug awaiting its NDA submission. Market Cap Market Cap 2,708,536 is incredibly low. This stock is set for a massive move. It's the best bar
CTOR
Rambo Rell Rambo Rell 4 minutes ago
$ILLR 🌍 Triller is tapping into international markets, expanding its footprint in Asia, Europe, and beyond. Global reach means exponential growth potential. Don’t wait until it’s too late. #GlobalExpansion
ILLR
georgie18 georgie18 4 minutes ago
Great way to start the year...🥳
XPON
Rambo Rell Rambo Rell 4 minutes ago
$ILLR 🌍 Triller is tapping into international markets, expanding its footprint in Asia, Europe, and beyond. Global reach means exponential growth potential. Don’t wait until it’s too late. #GlobalExpansion
ILLR
bri123 bri123 4 minutes ago
Best of luck to you in your other ventures. I hope to at least get some money back from this.
THBD
Hoskuld Hoskuld 4 minutes ago
The peer-reviewed paper sure makes it seem, in the opinion of the 50 world-class neurologists who authored it, that approval should be no-brainer. But, we can't move the needle to 100% yet.
AVXL
JohnnyRodz JohnnyRodz 4 minutes ago
Why is AABB on a Failure To Deliver List if it's NOT shorted! How can that happen?
AABB
powerbattles powerbattles 4 minutes ago
$BNRG $1.17 O/S 2M --- From development to commercialization—this could be a potential turnaround play with significant upside if the company executes well. Their product is impressive, especially considering it can save $7.5 million in energy costs. That's truly groundbreaking technology.
ht
BNRG
georgie18 georgie18 4 minutes ago
XPON...$3.79...🥳Plus 60% so far...

georgie18

Member Level
Re: georgie18 post# 387703

Monday, December 30, 2024 2:46:22 PM

Post#
387717
of 387841
XPON...$2.96...🥳Like to see the $3 Breakout...
XPON
kym1216 kym1216 4 minutes ago
Yes....they pump and dump with social media. Obviously it is your first minute on the OTC
IQST
jdes jdes 4 minutes ago
As the saying goes.....play stupid games, win stupid prizes. Got what he deserved.
CGAC
georgie18 georgie18 5 minutes ago
XPON...$3.79...🥳Plus 60% so far...

georgie18

Member Level
Re: georgie18 post# 387703

Monday, December 30, 2024 2:46:22 PM

Post#
387717
of 387841
XPON...$2.96...🥳Like to see the $3 Breakout...
XPON
powerbattles powerbattles 5 minutes ago
$BNRG $1.17 O/S 2M --- From development to commercialization—this could be a potential turnaround play with significant upside if the company executes well. Their product is impressive, especially considering it can save $7.5 million in energy costs. That's truly groundbreaking technology.
ht
BNRG
georgie18 georgie18 5 minutes ago
XPON...$3.79...🥳Plus 60% so far...

georgie18

Member Level
Re: georgie18 post# 387703

Monday, December 30, 2024 2:46:22 PM

Post#
387717
of 387841
XPON...$2.96...🥳Like to see the $3 Breakout...
XPON
Bruce the Stock Guy Bruce the Stock Guy 5 minutes ago
$AUNXF..First two modular data centres scheduled to be operating this month with data processing equipment and associated infrastructure being transported to site this week. AXP will generate revenue from gas-to-power supply, infrastructure maintenance and power uptime bonuses.
The first site
AUNXF AXP
Juntao Juntao 5 minutes ago
$AUTR https://www.otcmarkets.com/stock/AUTR/security
AUTR
Clark6290 Clark6290 5 minutes ago
Lol, failed investigation isn't much to celebrate.

Full speed ahead.
FNMA
powerbattles powerbattles 5 minutes ago
$BNRG $1.17 O/S 2M --- From development to commercialization—this could be a potential turnaround play with significant upside if the company executes well. Their product is impressive, especially considering it can save $7.5 million in energy costs. That's truly groundbreaking technology.
ht
BNRG
Trooperstocks Trooperstocks 5 minutes ago
$ZENA NEWS: ZenaTech Opens a Beyond Visual Line of Sight (BVLOS) Drone Testing Facility in Turkey for US Defense and NATO-Destined ZenaDrone 1000 Drones
ZenaTech Inc.
Thu, January 2, 2025 at 7:30 AM EST 8 min read


In This Article:
ZENA

Zena
ZENA
Bruce the Stock Guy Bruce the Stock Guy 6 minutes ago
$AUNXF..First two modular data centres scheduled to be operating this month with data processing equipment and associated infrastructure being transported to site this week. AXP will generate revenue from gas-to-power supply, infrastructure maintenance and power uptime bonuses.
The first site
AUNXF AXP

Your Recent History

Delayed Upgrade Clock